FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs
Sung-Suk Suh(The Ohio State University), Carlo M. Croce(The Ohio State University), Rami I. Aqeilan(Cancer Genetics (United States)), Balveen Kaur(Augusta University), Ri Cui(Wenzhou Medical University), Taek‐Kyun Lee(Korea Institute of Ocean Science and Technology), Kay Huebner(The Ohio State University Wexner Medical Center), Ji Young Yoo(The University of Texas MD Anderson Cancer Center)
Cited by 68
Related Papers
The role of MicroRNAs in human cancer
|Signal Transduction and Targeted Therapy|2016|2.5k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias
|Proceedings of the National Academy of Sciences|2004|1.3k
Molecular Cloning of the Interleukin-1β Converting Enzyme
|Science|1992|1.1k